Research Center for Stem Cell and Regenerative Medicine, Sichuan Neo-life Stem Cell Biotech INC, Chengdu, Sichuan, China.
Department of Ophthalmology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
Sci Rep. 2018 Mar 22;8(1):5014. doi: 10.1038/s41598-018-23396-1.
Mesenchymal stem/stromal cells (MSCs) derived from placental tissue show great therapeutic potential and have been used in medical treatment, but the similarity and differences between the MSCs derived from various parts of the placenta remain unclear. In this study, we compared MSCs derived from different perinatal tissues, including the umbilical cord (UC), amniotic membrane (AM), chorionic plate (CP) and decidua parietalis (DP). Using human leukocyte antigen (HLA) typing and karyotype analysis, we found that the first three cell types were derived from the foetus, while the MSCs from the decidua parietalis were derived from the maternal portion of the placental tissue. Our results indicate that both foetal and maternal MSCs share a similar phenotype and multi-lineage differentiation potential, but foetal MSCs show a significantly higher expansion capacity than do maternal MSCs. Furthermore, MSCs from all sources showed significant differences in the levels of several paracrine factors.
来源于胎盘组织的间充质干细胞(MSCs)具有巨大的治疗潜力,已被用于医疗,但来源于胎盘不同部位的 MSCs 之间的相似性和差异性尚不清楚。在这项研究中,我们比较了来源于不同围产期组织的 MSCs,包括脐带(UC)、羊膜(AM)、胎盘绒毛膜(CP)和胎盘壁蜕膜(DP)。通过人类白细胞抗原(HLA)分型和核型分析,我们发现前三种细胞类型来源于胎儿,而来源于胎盘壁蜕膜的 MSCs 则来源于胎盘组织的母体部分。我们的结果表明,胎儿和母体来源的 MSCs 具有相似的表型和多向分化潜能,但胎儿来源的 MSCs 具有明显更高的扩增能力。此外,所有来源的 MSCs 在几种旁分泌因子的水平上表现出显著差异。